"The WHO [World Health Organization] asked us if we could share the biological material and if we could rerun the tests in an independent laboratory."
"We accepted."
"None of the studies published so far have ever questioned the geographical origin [of SARS-CoV-2]."
"The growing doubt is that the virus, probably less powerful compared to later months, was circulating in China long before the reported cases."
Giovanni Apolone, scientific director, Milan Cancer Institute
Study: Unexpected detection of SARS-CoV-2 antibodies in the prepandemic period in Italy. Image Credit: columbo.photog / Shutterstock
The World Health Organization requested of two scientists who had led Italian research into the first appearances of the novel coronavirus that samples from a study suggested the coronavirus was circulating outside China by October of 2019 undergo re-testing. This, in the face of discomfort at the WHO over growing international pressure to investigate more deeply the origins of the global pandemic that has succeeded in ending the lives of over three million people globally.
And nor is the WHO particularly enamoured of U.S.President Biden's announcement that American intelligence agencies were directed by him to pursue the issue of rival theories inclusive of the possibility that a laboratory 'escape' accident in China unleashed this killer virus on the world body. Their response was that the search for answers was being "poisoned by politics". Whereas it is more than likely that politicians and scientists want to understand what, who and why caused this pandemic to stalk the world.
Its predatory presence first identified in the Chinese megacity of Wuhan in December of 2019, Italy's first patient with COVID-19 was diagnosed on the 21st of February, 2020 in a small town close to Milan. Last year a published study revealed evidence that antibodies to the virus or a variant thereof was detected in 2019, in Italy. Information that Beijing gratefully grasped and ran with as proof-positive that the SARS-CoV-2 virus causing COVID emanated not from China, but Italy.
In response, the Italian researchers emphasized that the findings served to raise questions relating to when the virus first emerged, not where it emanated from. "WHO is in contact with the researchers that had published the original paper. A collaboration with partner laboratories has been set up for further testing", explained a spokesperson for the World Health Organization. WHO, the United Nations agency that has just elected Syria to its board.
The Syrian regime knows quite a bit about mass killing. Fit to sit on the world body's health board. After all, it is an impressive number, a half-million Syrians dying at the military hands of their own government, who used poison chemicals, barrel bombs and helicopter gunships to penalize its citizens who questioned the right of a tyrannical government to disorder their lives.
The UN agency has made contact with all researchers who published or provided information on samples collected in 2019 that were known to have tested positive for SARS-CoV-2. And similarly the spokesperson mentioned that the WHO, aware the researchers plan to publish a follow-up report "in the near future" wants to keep ahead of results, interpretations and claims.
Published by the INT's scientific magazine Tumori Journal, the Italian researchers' findings showed the presence of neutralizing antibodies to SARS-CoV-2 isolated in blood drawn from healthy volunteers in Italy in October 2019 during a lung cancer screening trial. Those volunteers came from Lombardy, which happens to be the northern region adjacent Milan -- the first and hardest hit in Italy, by the virus.
Coronavirus vaccination in Iseo, Italy, on February 26, 2021. As the third wave of Covid-19 pandemic ...NurPhoto via Getty Images
Abstract
There
are no robust data on the real onset of severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) infection and spread in the
prepandemic period worldwide. We investigated the presence of SARS-CoV-2
receptor-binding domain (RBD)–specific antibodies in blood samples of
959 asymptomatic individuals enrolled in a prospective lung cancer
screening trial between September 2019 and March 2020 to track the date
of onset, frequency, and temporal and geographic variations across the
Italian regions. SARS-CoV-2 RBD-specific antibodies were detected in 111
of 959 (11.6%) individuals, starting from September 2019 (14%), with a
cluster of positive cases (>30%) in the second week of February 2020
and the highest number (53.2%) in Lombardy. This study shows an
unexpected very early circulation of SARS-CoV-2 among asymptomatic
individuals in Italy several months before the first patient was
identified, and clarifies the onset and spread of the coronavirus
disease 2019 (COVID-19) pandemic. Finding SARS-CoV-2 antibodies in
asymptomatic people before the COVID-19 outbreak in Italy may reshape
the history of pandemic.
This represents a general opinion site for its author. It also offers a space for the author to record her experiences and perceptions,both personal and public. This is rendered obvious by the content contained in the blog, but the space is here inviting me to write. And so I do.
<< Home